[HTML][HTML] Challenges in cost-effectiveness analysis modelling of HPV vaccines in low-and middle-income countries: a systematic review and practice recommendations

OI Ekwunife, JF O'Mahony, A Gerber Grote… - …, 2017 - Springer
… inspection with acetic acid (VIA) and the human papillomavirus (HPV) DNA test [2] and thus
treated at an earlier stage, thereby improving survival. The disease can also be prevented by …

[HTML][HTML] Model comparisons of the effectiveness and cost-effectiveness of vaccination: a systematic review of the literature

M Drolet, É Bénard, M Jit, R Hutubessy, M Brisson - Value in Health, 2018 - Elsevier
… This rise is mostly attributable to the publication of comparative modeling studies of human
papillomavirus (HPV) and influenza vaccination. The six comparative modeling studies using …

Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States

JF Laprise, HW Chesson, LE Markowitz… - Annals of internal …, 2020 - acpjournals.org
… The impact of human papillomavirus vaccination in the United States: insights from comparing
mathematical model predictions and surveillance data. Presented at 32nd International …

Cost-effectiveness analyses of human papillomavirus vaccination

AT Newall, P Beutels, JG Wood… - The Lancet infectious …, 2007 - thelancet.com
… as relating to vaccine effectiveness, cervical screening, and model design. Although the
studies suggest that the introduction of an HPV vaccine could be cost effective compared with …

[PDF][PDF] Human papilloma virus vaccination–a systematic review of cost-effectiveness analyses

S Čavaljuga, H Ćubro, S Izetbegović - South Eastern Europe Health …, 2013 - unvi.edu.ba
effective (8). We wanted to explore in which circumstances it is cost effective. The aim of our
study was to evaluate when HPV vaccination is cost effective and to evaluate circumstances …

Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience

SM Garland, SK Kjaer, N Muñoz… - Reviews of Infectious …, 2016 - academic.oup.com
vaccine, which is the most widely used HPV vaccine in many countries around the world.
Our systematic review … the reported effectiveness and impact of 4vHPV vaccination on HPV …

[PDF][PDF] Cost-effectiveness of HPV-vaccination in medium or low income countries with high cervical cancer incidence—a systematic review

K Natunen, TA Lehtinen, S Torvinen… - … and Vaccination, 2013 - nitag-resource.org
… High-risk (hr) human papilloma virus infection is the necessary cause of cervical cancer,
infections with [3] hrHPV types 16 and 18 being the most prominent causes [4,5]. It has also …

Cost-effectiveness of extending the HPV vaccination to boys: a systematic review

R Linertová, C Guirado-Fuentes, JM Medina… - J Epidemiol …, 2021 - jech.bmj.com
… . The ethics of implementing human papillomavirus vaccination in developed countries.
Med Health Care Philos 2011;14:19–27.doi:10.1007/s11019-010-9285-9 pmid:http://www.ncbi.…

[HTML][HTML] Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

M Jit, N Demarteau, E Elbasha, G Ginsberg, J Kim… - BMC medicine, 2011 - Springer
… that the cost effectiveness of introducing human papillomavirus (HPV) vaccination is … A
literature review identified six HPV vaccination models suitable for low-income and middle…

[HTML][HTML] Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis

JJ Kim, KT Simms, J Killen, MA Smith, EA Burger… - PLoS …, 2021 - journals.plos.org
… A nonavalent human papillomavirus (HPV) vaccine has been licensed for use in women
and men up to age 45 years in the United States. The cost-effectiveness of HPV vaccination for …